Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market – Insights

Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others.

The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers

Increasing number of surgical procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures statistics’ of Eurostat in November 2019, at least 1.4 million caesarean sections performed in the EU in 2017.

Moreover, high incidence of early postoperative small bowel obstruction is also expected to aid in growth of the market. For instance, according to the study, “Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications”, published in the American Journal of Obstetrics and Gynecology, in March 2019, the incidence rate of early small bowel obstructions was 5.9 per 1000 hysterectomies and 43.7% of the study population developed small bowel obstruction during the initial hospital stay and 23.1% underwent reoperation.

High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.      

Statistics:

Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers  | Coherent Market Insights

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Restraints

Bringing a single new product of hemostat, tissue sealant or adhesion barriers in the market costs tremendous investment and long duration. For instance, time involved in the clinical and pre-clinical trials for these products is as high as 10 years or more.

Stringent federal approval procedures for new products are exerting significant difficulties for market development. Furthermore, some surgical sealants demonstrate less glue quality and have restricted applications. Such scenario also limits growth of the market.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Opportunities

Increasing incidence of injuries and burns is expected to offer lucrative growth opportunities for players in the market. For instance, according to the World Health Organization’s March 2018 key facts,  an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries.

Use of bone glue, tissue sealants & bio sealants helps reduce cross-contamination, aids in healing process, and decreases blood loss due to surgical stiches and staplers and improves quality of patient care. Increasing awareness among physicians about benefits such as reduced cost of post-surgical complications treatment and reduced hospital stay post-surgery due to faster healing and recovery of surgical wounds is also expected to aid in growth of the market.

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing prevalence of cardiovascular disease (CVD) is expected to boost growth of the market in North America. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, CVD was responsible for 840,768 deaths (635,260 cardiac) in 2016 in the U.S.

Increasing number of surgical procedures is expected to aid in growth of the market in Asia Pacific. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers  | Coherent Market Insights

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Competitive Landscape 

Major players operating in the global surgical hemostats, internal tissue sealants and adhesion barriers market include, Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Key Developments 

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in March 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched SURGICEL POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.

Major players in the market are also focussed on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Baxter International Inc. competed acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi.

Surgical hemostats, internal tissue sealants, and adhesion barriers are medical procedures/devices used to control bleeding after injuries, and during surgical procedures. Hemostats, also referred to as hemostatic clamp, arterial forceps or pean are surgical tools used in surgical procedures to control bleeding. The hemostats were designed to clamp blood vessels of small size to manage blood flow in hemorrhagic cases. These devices are also used to grasp and secure superficial fascia during wound closure surgical procedures. The hemostats, with hinges and rings, are visibly similar to scissors.

Restraints of the Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market

The high cost involved in R&D of surgical hemostats, internal tissue sealants, and adhesion barriers technology-based products and limited financial support has posed a great challenge to growth of the global surgical hemostats, internal tissue sealants, and adhesion barriers market.

Key features of the study:

  • This report provides in-depth analysis of the global surgical hemostats, internal tissue sealants, and adhesion barriers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global surgical hemostats, internal tissue sealants, and adhesion barriers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global surgical hemostats, internal tissue sealants, and adhesion barriers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type:
    • Hemostats
      • Thrombin Based
      • Combination Hemostats
      • Oxidized Regenerated Cellulose Based
      • Gelatin Based
      • Collagen Based
    • Internal Tissue Sealants
      • Fibrin Based
      • Collagen Based
      • Protein Based
      • Synthetic Polymer Based
    • Adhesion Barriers
      • Film Based
      • Gel Based
      • Solution Based
  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Application:
    • Surgical Applications
      • Cardiovascular Surgeries
      • Neurological Surgeries
      • Orthopedic Surgeries
      • Urological & Gynecological Surgeries
      • General Surgeries
      • Reconstructive and Plastic Surgeries
      • Others
    • Trauma Cases
  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Geography:
    • North America
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country:
          • S.
          • Canada
    • Europe
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country:
          • K.
          • Germany
          • Italy
          • France
          • Spain
          • Russia
          • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country:
          • China
          • India
          • Japan
          • ASEAN
          • Australia
          • South Korea
          • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country:
          • Brazil
          • Mexico
          • Argentina
          • Rest of Latin America
    • Middle East:
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country:
          • GCC
          • Israel
          • Rest of Middle East
    • Africa
      • By Product Type
        • Hemostats
          • Thrombin Based
          • Combination Hemostats
          • Oxidized Regenerated Cellulose Based
          • Gelatin Based
          • Collagen Based
        • Internal Tissue Sealants
          • Fibrin Based
          • Collagen Based
          • Protein Based
          • Synthetic Polymer Based
        • Adhesion Barriers
          • Film Based
          • Gel Based
          • Solution Based
        • By Application
          • Surgical Applications
            • Cardiovascular Surgeries
            • Neurological Surgeries
            • Orthopedic Surgeries
            • Urological & Gynecological Surgeries
            • General Surgeries
            • Reconstructive and Plastic Surgeries
            • Others
          • Trauma Case
        • By End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Specialty Clinics
        • By Country/Region:
          • Central Africa
          • South Africa
          • North Africa
  • Company Profiles
    • Ethicon (Johnson & Johnson)*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Baxter International Inc.
    • Integra LifeSciences Holdings Corporation
    • Pfizer Inc.
    • Tissuemed Ltd.
    • Sanofi
    • Braun Melsungen AG
    • R. Bard, Inc.
    • CryoLife, Inc.
    • Cohera Medical, Inc.
    • CSL Behring

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Product Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hemostats
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • Thrombin Based
        • Combination Hemostats
        • Oxidized Regenerated Cellulose Based
        • Gelatin Based
        • Collagen Based
    • Internal Tissue Sealants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • Fibrin Based
        • Collagen Based
        • Protein Based
        • Synthetic Polymer Based
    • Adhesion Barriers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • Film Based
        • Gel Based
        • Solution Based
  5. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Application, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Surgical Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Cardiovascular Surgeries
        • Neurological Surgeries
        • Orthopedic Surgeries
        • Urological & Gynecological Surgeries
        • General Surgeries
        • Reconstructive and Plastic Surgeries
        • Others
    • Trauma Cases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Ethicon (Johnson & Johnson)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Integra LifeSciences Holdings Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Tissuemed Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • C.R. Bard, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • CryoLife, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cohera Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • CSL Behring
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 24 figures on “Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market – Global forecast to 2027.

Frequently Asked Questions

This report provides in-depth analysis of the Global surgical hemostats, internal tissue sealants, and adhesion barriers Market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2019 – 2027). The report also provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Key segments covered in the report include: o By Product Type o By Application o By End User o By Region
The report provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
The report profiles leading players in the Global surgical hemostats, internal tissue sealants, and adhesion barriers Market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner